CBER Touts Gene Therapy, Vaccine Approvals in FY2018

Drug Industry Daily
A A
CBER Director Peter Marks highlighted two gene therapy approvals in a report on the center’s achievements for fiscal 2018, released on Wednesday.

To View This Article:

Login

Subscribe To Drug Industry Daily